Weak outcome predictors of multimodal rehabilitation at one-year follow-up in patients with chronic pain—a practice based evidence study from two SQRP centres by unknown
RESEARCH ARTICLE Open Access
Weak outcome predictors of multimodal
rehabilitation at one-year follow-up in
patients with chronic pain—a practice
based evidence study from two SQRP
centres
Björn Gerdle1*, Peter Molander1,2, Gunilla Stenberg3, Britt-Marie Stålnacke4 and Paul Enthoven1,5
Abstract
Background: For patients with chronic pain, the heterogeneity of clinical presentations makes it difficult to identify
patients who would benefit from multimodal rehabilitation programs (MMRP). Yet, there is limited knowledge
regarding the predictors of MMRP’s outcomes. This study identifies predictors of outcome of MMRPs at a 12-month
follow-up (FU-12) based on data from the Swedish Quality Registry for Pain Rehabilitation (SQRP).
Methods: Patients with chronic pain from two clinical departments in Sweden completed the SQRP
questionnaires—background, pain characteristics, psychological symptoms, function, activity/participation, health and
quality of life—on three occasions: 1) during their first visit; 2) immediately after the completion of their MMRP; and 3)
12 months after completing the MMRP (n = 227). During the FU-12, the patients also retrospectively reported their
global impressions of any changes in their perception of pain and their ability to handle their life situation in general.
Results: Significant improvements were found for pain, psychological symptoms, activity/participation, health, and
quality of life aspects with low/medium strong effects.
A general pattern was observed from the analyses of the changes from baseline to FU-12; the largest improvements in
outcomes were significantly associated with poor situations according to their respective baseline scores. Although
significant regressors of the investigated outcomes were found, the significant predictors were weak and explained a
minor part of the variation in outcomes (15–25%). At the FU-12, 53.6% of the patients reported that their pain had
decreased and 80.1% reported that their life situation in general had improved. These improvements were associated
with high education, low pain intensity, high health level, and work importance (only pain perception). The explained
variations were low (9–11%).
Conclusions: Representing patients in real-world clinical settings, this study confirmed systematic reviews that
outcomes of MMRP are associated with broad positive effects. A mix of background and baseline variables influenced
the outcomes investigated, but the explained variations in outcomes were low. There is still a need to develop
standardized and relatively simple outcomes that can be used to evaluate MMRP in trials, in clinical evaluations at
group level, and for individual patients.
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Background
Approximately 20% of the adult population lives with at
least moderate chronic pain [1]. Patients with chronic
pain describe wide consequences such as intense and
disturbing pain, psychological distress and insomnia, re-
duced work ability and sick-leave, ill-health, and low qual-
ity of life [2–6]. According to Years Lived with Disability
(YLDs), a measure of non-fatal health outcomes, pain
conditions caused 21% of all YLDs globally ahead of 287
other conditions [7]. The five leading conditions of YLDs
in Sweden were low back pain, major depressive disorder,
falls, neck pain, and other musculoskeletal disorders.
Acute and chronic pain are influenced by and interact
with physical, psychological, social, and contextual fac-
tors [8–10], thus a bio-psycho-social framework should
be considered in clinical practice [11, 12]. Multimodal
(i.e., multidisciplinary) rehabilitation programs (MMRPs)
are complex interventions based on such a framework and
usually continue over several weeks with both general and
patient specific goals. Common components of MMRPs
are education, supervised physical activity, training in sim-
ulated environments, cognitive behavioural therapy (CBT),
and work-related efforts. These components can act inde-
pendently and interdependently resulting in a combination
of effects explained by known and unknown mechanisms
and these effects are intended to be greater than the sum
of its components [13, 14]. The components are coordi-
nated and delivered by a team of different professionals,
but an important prerequisite is that the patient is an active
participant [15–18].
MMRPs represent important evidence-based progress in
treatment for patients with chronic pain [16–21]. Although
there is some evidence that MMRPs are effective, the effect
sizes are generally small to moderate. Randomized con-
trolled trials (RCT) and systematic reviews (SR) may reflect
artificial situations with regard to unrepresentative selec-
tion of patients, risk for researcher allegiance, and prob-
lems with practical applications of the interventions
investigated [22, 23]. Thus, a complementary necessary
step is to investigate whether the evidence reported from
RCTs and SRs also holds for a consecutive non-selected
flow of patients in real-world practice settings. This re-
search methodology—practice based evidence (PBE)—is
based on prospective observational cohort study designs
and has also been applied in rehabilitation research [24].
Patients with chronic pain exhibit heterogeneous clin-
ical presentations and the question arises if certain pa-
tient characteristics are indicative of outcomes after
MMRP. Answering these questions are important as
MMRPs are time consuming and expensive even when
most of the activities for the patients are group based.
Little is known about outcome predictors of MMRPs
[18, 25–30]. It is likely that a combination of predictor
variables can be identified [30]. Some of the available
predictive studies are based on RCTs, but these RCTs
have a small sample of patients and may have limited
relevance to MMRP in clinical practice [31–33]. Predic-
tion studies based on clinical samples are needed to reli-
ably identify who actually benefits from inclusion and
participation in MMRPs.
This PBE study identifies predictors of outcome of
MMRPs for patients with chronic pain based on data
from the Swedish Quality Registry for Pain Rehabilita-
tion (SQRP) (www.ucr.uu.se/nrs/) for two multidisciplin-
ary pain centres in Sweden. Six outcome domains were
identified (pain intensity, physical functioning, emotional
functioning, coping, health and ratings of global im-
provements) mainly according to the recommendations
of the IMMPACT-group [12, 34].
Methods
Subjects
This study collected data using the SQRP on 464 patients
between 18 and 65 years old who had chronic mainly
musculoskeletal pain. These patients were referred to the
Pain and Rehabilitation Centre at University Hospital of
Linköping or the Pain Rehabilitation Clinic at University
Hospital of Umeå between 2008 and 2012. In total, 464
patients with chronic pain were referred to these two
facilities to participate in a MMRP. The present study
is primarily based on patients who answered the
SQRP both at baseline (before the MMRP) and at the
12-month follow-up (n = 227).
MMRP at the two sites
At the Umeå site, the referred patients were assessed by
teams consisting of a specialist physician in rehabilita-
tion medicine or by specialists in training under supervi-
sion of a senior colleague, a physiotherapist, a social
worker, and a psychologist and occupational therapist if
needed. If the team considered that the patient needed
MMRP and fulfilled the inclusion criteria (disabling
chronic pain, on sick leave or experiencing major inter-
ference in daily life, no further investigations needed)
they were accepted to participate in the program. The
MMRP was conducted in groups of six to nine partici-
pants and was based on CBT principles and included
physiotherapy, ergonomics, training in coping strategies,
and education in pain management. The patients were
encouraged to take an active part in goal setting. At the
Linköping site, medical assessments were performed by
senior physicians, primarily from specialists in rehabilita-
tion medicine or similar specialities, or by specialists in
training under the supervision of a senior colleague. The
majority of the participants were also assessed by a
psychologist, an occupational therapist, and a physio-
therapist. The Linköping program followed the same
main principles as the Umeå program—group treatment
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from a CBT perspective, group physiotherapy, interven-
tions targeting improved ergonomics, and occupational
therapy. At both sites the MMRPs lasted between 6 and 8
weeks for at least 20 h per week of group-based activities.
In addition, lectures in basic pain science and pain man-
agement were offered for both patients (both sites) as well
as for relatives, friends, and colleagues (only Linköping).
Both programs included work related advice and support,
and individually tailored sessions with team members
were available. Further individual sessions might also be
required for a few weeks following the program.
The following inclusion criteria for the MMRP were
used: (i) disabling chronic pain (on sick leave or experi-
encing major interference in daily life due to chronic
pain); (ii) age between 18 and 65 years; (iii) no further
medical investigations needed; (iv) written consent to
participate and attend to the MMRP;(v) and agreement
not to participate in other parallel treatments. The fol-
lowing exclusion criteria were used: (i) ongoing major
somatic or psychiatric disease; (ii) a history of significant
substance abuse; and (iii) state of acute crisis. General
exclusion criteria included severe psychiatric morbidity,
abuse of alcohol and/or drugs, diseases that did not
allow physical exercise, and specific pain conditions with
other treatments options available (red flags).
Methods
The SQRP is recognized as a national registry by the
Swedish Association of Local Authorities and Regions. The
SQRP is mainly based on questionnaires. The patients com-
pleted the SQRP questionnaires on three occasions: 1) at
the assessment during the first visit to the clinical depart-
ment (pre-MMRP or baseline); 2) immediately after MMRP
(post-MMRP); and 3) at the 12-month follow-up (FU-12).
Demographic data are only collected before MMRP. In the
present study, the predictions concerned the FU-12.
The main purpose of the SQRP is to present the results
of MMPR at a group level to the participating clinical de-
partments. Based on these data, health care providers and
researchers can develop a process that will encourage con-
tinued improvement of rehabilitation programs. In a review
of the overall quality of approximately 60 nationwide regis-
tries, the Boston Consulting Group considered the SQRP
as one of the top ten national registries in Sweden [35].
The SQRP includes descriptive variables of the pa-
tients’ background, pain characteristics, other symptoms
such as depression and anxiety, function, activity/partici-
pation, and quality of life. Generally validated Swedish
language versions of the instruments were used.
Data from the SQRP
Listed below are the variables and instruments of the
SQRP that this study used. These are also summarized




 Education (elementary school, upper secondary
school, University or college or other). This variable
was dichotomized into University vs the other
alternatives.
 Country of birth (Sweden, Another Nordic country,
Europe except Nordic country, or Country outside
Europe). This variable was dichotomized into Nordic
countries vs. outside Nordic countries.
 Currently working/studying (Yes or No) denoted
Work/study-now.
 Three items concerned the attitude about the
future. Those working/studying full time were
instructed to skip the first two items below;
subjects who were seeking a job were instructed
to imagine being employed when answering the
following items:
○ What do you think it will be like to return to
work/studies or to extend working hours if you
are not working full time? (Likert scale: 1 (very
easy) to 5 (very difficult). This variable was
denoted as Own prognosis-RTW.
○ When do you expect to be able to return to
work or studies or to work longer if you are not
working full time? (Likert scale: 1 (immediately)
to 5 (never). This variable was denoted as
RTW-when.
○ How confident are you about your chances to
be fully restored? Likert scale: 1 (totally convinced)
to 5 (not at all convinced). This variable is denoted
as Chances-restored.
 What significance does the work have for you in
addition to the importance of income? (Five
alternatives: 1) Very important, 2) Important, 3)
Partially important, 4) Hardly no importance, or 5)
No importance). This variable was denoted as
Work-importance.
Characteristics of pain
 How many times have you visited a physician for
your pain complaints the previous year? 0–1 times;
2–3 times; or ≥4 times). This variable was
dichotomized into ≥4 times vs. the other alternatives
and is denoted as Dr-visits.
 When did you first experience the pain you are
currently troubled by? (days). This variable was
denoted as Pain-duration.
 If persistent pain exists, how long? (days). This
variable was denoted as Pain-duration-persistent.
 Average pain intensity the last week (a numeric
rating scale 0–10 with numbers for guidance and
the end points also had verbal descriptions
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(0 = no pain and 10 = worst possible pain). This is
denoted as NRS-7days.
 Using 36 predefined anatomical areas (18 on the
front and 18 on the back of the body), the subjects
marked where they experienced pain: 1) head/face,
2) neck, 3) shoulder, 4) upper arm, 5) elbow, 6)
forearm, 7) hand, 8) anterior aspect of chest, 9)
lateral aspect of chest, 10) belly, 11) sexual organs,
12) upper back, 13) low back, 14) hip/gluteal area,
15) thigh, 16) knee, 17) shank, and 18) foot. The
number of areas associated with pain were counted
(between 0 and 36) and this variable was labelled the
Pain Region Index (PRI).
Multidimensional Pain Inventory (MPI)
The West Haven-Yale Multidimensional Pain Inven-
tory—(WHY) MPI—is a 61-item self-report questionnaire
that measures psychosocial, cognitive, and behavioural ef-
fects of chronic pain [36, 37]. Part 1 consists of five scales:
Pain severity (MPI-Pain-severity); Interference—pain re-
lated interference in everyday life (MPI-PainInterfer);
Perceived Life Control (MPI-LifeCon); Affective Distress
(MPI-Distress); and Social Support—perceived support
from a spouse or significant others (MPI-SocSupp). Part 2
was not used in this study. Part 3 measures to what extent
the patients engaged in various activities using four scales.
These scales can be combined into a composite scale—the
General Activity Index (MPI-GAI)—which was used in the
present study [38].
Hospital Anxiety and Depression Scale (HADS)
The HADS is a self-assessment questionnaire that mea-
sures anxiety and depression using 14 items [39]. HADS
comprises seven items in each of the depression and anx-
iety scales (HAD-D—depression and HAD-A—anxiety).
The subscale scores range between 0 and 21, with the
lower score indicating the least depression and anxiety
possible. HADS is frequently used both in clinical practice
and in research and has good psychometric characteristics
[39, 40]. It is also validated in its Swedish translation [41].
The Chronic Pain Acceptance Questionnaire (CPAQ)
CPAQ measures acceptance behaviours and attitudes to-
wards pain. The process of acceptance refers to the con-
cept of coping with pain; this process changes the focus
from controlling pain and related psychological experi-
ences to a wider focus that includes being open to pain
without trying to alter the experience. Acceptance in-
cludes flexible engagement in goal-directed activities,
which include pain as a part of the engagement, without
struggling to control pain. CPAQ is a 20-item scale with
two subscales: activity engagement (score range: 0–66;
denoted CPAQ-AE) and pain willingness (score range:
0–54; denoted CPAQ-PW) [42]. All items are rated on a
scale from 0 (never true) to 6 (always true). The CPAQ
has shown to be reliable and valid both in the English
and Swedish versions [42, 43].
The Tampa Scale for Kinesiophobia (Tampa)
Tampa measures fear of movement [44]. The items are
rated on a four-point Likert scale from “strongly dis-
agree” to “strongly agree”. The total score has a range
from 17 to 68; scores higher than 36 for women and
higher than 38 for men indicate high pain-related fear
[45]. Tampa has shown to be a reliable assessment tool
in chronic pain populations [44, 46]. A study including
Dutch, Canadian, and Swedish samples with several dif-
ferent pain types demonstrated that the factor structure
was stable across pain diagnoses and nationalities [45].
Life Satisfaction Questionnaire (LISAT-11)
LISAT-11 captures the patient’s estimations of satisfac-
tion with life as a whole (LISAT-life) as well as satisfac-
tion in ten specific domains [47]. Each item has six
possible answers: 1 = very dissatisfying; 2 = dissatisfying;
3 = fairly dissatisfying; 4 = fairly satisfying; 5 = satisfying;
and 6 = very satisfying. This study used LISAT-life to-
gether with the following specific items: satisfaction with
vocation (LISAT-vocation); satisfaction with economy
(LISAT-economy); satisfaction with activities of daily liv-
ing (ADL) (LISAT-ADL); satisfaction with somatic health
(LISAT-somhealth); and satisfaction with psychological
health (LISAT-psychhealth).
The Short Form Health Survey (SF36)
SF36 intends to represent multidimensional health con-
cepts and measurements of the full range of health
states, including levels of well-being and personal evalu-
ations of health [48]. The instrument has eight dimen-
sions (reported using a standardized scale from 0 to 100)
[48]. In the present study the scale concerning physical
functioning (SF36-PF) was selected. Based on the eight
scales, a physical summary component (SF36-PSC) and
a mental (psychological) summary component (SF36-
MSC) are calculated. Hence, this study used these two
summary components together with SF36-PF.
The European Quality of Life instrument (EQ-5D)
EQ-5D captures a patient’s perceived state of health
[49–51]. The first part of the instrument defines five
dimensions: mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression. Using these five di-
mensions, the instrument calculates an index (EQ5D-
Index). The EQ5D also measures self-estimation of today’s
health according to a 100-point scale, a thermometer-like
scale (EQ5D-VAS) with defined end points (high values
indicate good health and low values indicate bad health).
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Retrospective ratings of global improvements in pain and in
life situation
The patients retrospectively at FU-12 reported their glo-
bal evaluations of change in pain (labelled Retro-pain)
and their ability to handle life situation in general (la-
belled Retro-life situation). The Retro-pain item was
rated on a five-point Likert scale from markedly in-
creased pain (0) to markedly decreased pain (4). The
other item was rated on a five-point Likert scale from
markedly worsened (0) to markedly improved (4). In the
regressions, these two items were dichotomized (i.e., no
change/worse (0) vs. improved (1).
Core outcome domains and measures
In order to predict changes in outcomes, we, as far as
possible, chose to adopt the recommendations of the
IMMPACT group with regard to output domains and core
outcome measures for chronic pain trials [12, 34] and the
practical use in the systematic review of de Rooij et al.
[28]. In addition to these areas, we also defined two extra
domains labelled Coping and Health. When selecting
the outcome domains we also considered the contents
of the programs. Hence, the following six outcome
domains and measures were selected as outcomes in
the present study:
Pain intensity aspects
 Average pain intensity the last week (NRS-7days)
 Pain severity according to the Multidimensional
Pain Inventory (MPI-Pain severity)
Physical functioning
 Pain interference according to MPI (MPI-PainInterfer)
 Physical functioning according to Short form Health
Survey (SF36-PF)
Emotional functioning
 Depression according to Hospital Anxiety and
Depression Scale (HAD-D)
 Anxiety according to HADS (HAD-A)
 Distress according to MPI (MPI-Distress)
Coping
 Life control according to MPI (MPI-LifeCon)
 Activity engagement according to Chronic
Acceptance Questionnaire (CPAQ-AE)
 Pain willingness according to CPAQ
(CPAQ-PW)
 Tampa Scale for Kinesiophobia (Tampa)
Health
 perceived state of health (single item) according
to European Quality of Life Instrument
(EQ5D-VAS)
 perceived state of health (index) according to EQ
(EQ5D-index)
 Satisfaction with life in general (LISAT-life)
Ratings of global improvement
 Retrospective rating of global improvement in life
situation (Retro-pain)
 Retrospective rating of global improvement in life
situation (Retro-life situation)
Statistics
All statistics were performed using the statistical package
IBM SPSS Statistics (version 20.0) and SIMCA-P+ (ver-
sion 13.0; Umetrics Inc., Umeå, Sweden); in all tests, a
probability of <0.05 (two-tailed) was accepted as the cri-
teria for significance. In the tables and text, the mean
value ± one standard deviation (±1SD) of the investigated
variables are given.
Effect sizes of the rehabilitation program were calcu-
lated using the template developed by Lakens [52]. In
this paper, Cohen’s dav was seen as the most appropriate
way to present the effects as this uses the average standard
deviation of the two measurement points [53]. Roughly,
one can interpret the Cohen’s effect sizes using the
following criteria: d = 0.2 is small, d = 0.5 is medium,
and d = 0.8 is large [54]. Bonferroni correction was
used in the detailed analyses over time for the differ-
ent outcomes. Results were deemed significant at the
p = 0.00083 level.
Advanced multivariate analyses (MVDA) are essential in
PBE studies. Classical statistical methods such as multiple
linear regression (MLR) and logistic regression (LR) can
quantify the level of relations of individual factors but disre-
gard interrelationships among different factors and thereby
ignore system-wide aspects (e.g., when a group of variables
correlates with the investigated dependent outcome) [55].
Classical methods assume variable independence when
interpreting results [56]. Eriksson and co-workers discussed
the risks with considering one separate variable at a time
(COST)[57]. They point out that the COST approach has
serious drawbacks; the information in multivariate data
often remains hidden and there is a risk for spurious results
[57]. To handle these drawbacks, we used advanced MVDA
(i.e., Principal Component Analysis, PCA) for the multivari-
ate correlation analyses of all investigated variables and
Partial Least Square Regression (PLS) for the multivariate
regressions using SIMCA-P+. These techniques do not re-
quire normal distribution [58].
PCA was used to extract and display systematic vari-
ation in a data matrix. All variables were log transformed
before the statistical analyses if necessary. A cross valid-
ation technique was used to identify nontrivial compo-
nents (p). Variables loading on the same component p
were correlated, and variables with high loadings but with
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opposing signs were negatively correlated. Variables with
high absolute loadings—i.e., 95% jack-knife uncertainty
confidence interval non equal to zero—were considered
significant. Hence, the most important variables were those
with high absolute loadings. The obtained components are
per definition not correlated and are arranged in decreas-
ing order with respect to explained variation. R2 describes
the goodness of fit—the fraction of sum of squares of all the
variables explained by a principal component [59]. Q2 de-
scribes the goodness of prediction—the fraction of the total
variation of the variables that can be predicted by a princi-
pal component using cross validation methods [59]. Out-
liers were identified using two methods: 1) score plots in
combination with Hotelling’s T2 and 2) distance to model
in X-space. No extreme outliers were detected.
PLS was used for the multivariate regression analyses
[59]. The VIP variable (variable influence on projection)
indicates the relevance of each X-variable pooled over all
dimensions and Y-variables—the group of variables that
best explain Y. VIP ≥ 1.0 was considered significant if VIP
had 95% jack-knife uncertainty confidence interval non
equal to zero. The PLS analyses were made in two steps.
First, all potential regressor variables were entered. If this
regression was significant, regressors with VIP > 0.80 were
selected and used in the final PLS. Coefficients (PLS scaled
and centred regression coefficients, Coeff) were used to
note the direction of the relationship (positive or nega-
tive). SQRP uses predetermined rules when handling sin-
gle missing items of a scale or a subscale; details about
this is reported in Additional file 1: Table S6. SIMCA-P+,
in contrast to traditional statistical packages e.g. SPSS,
uses the NIPALS algorithm when compensating for miss-
ing data (i.e. in the present study the scales and subscales
of a certain subject).
MLR or LR could have been an alternative, but they
assume that the regressor (X) variables are independent.
If multicollinearity (i.e., high correlations) occurs among
the X-variables, the regression coefficients become un-
stable and their interpretability breaks down. MLR and
LR also assumes that a high subject-to-variables ratio is
present (e.g., > 5), an assumption not required for PLS.
In fact, PLS can handle subject-to-variables ratios < 1.




When comparing those who did not and who did complete
the questionnaire at FU-12, only one just barely significant
difference was found—the pain intensity variable NRS-
7days. Those who did not complete the questionnaire had
a mean score of 7.02 (SD 1.06) in comparison to those
who did (M= 6.61, SD = 1.89) (t(437) = 2.09, p = 0.04).
Hence, no statistically significant differences were found for
demographic variables, psychological well-being, quality of
life, acceptance, kinesiophobia, general health, or psycho-
logical functioning as measured by the SF-36.
Background data and characteristics of pain
Background data is reported in Table 1. The majority of
the patients were women (>80%). A significant propor-
tion (18.5–36.8%) expressed pessimistic views concern-
ing aspects of return to work (RTW) (Table 1).
The number of anatomical regions with pain (PRI) was
14.7 ± 7.9 out of 36 anatomical regions. Mean pain dur-
ation was 2550 ± 2609 days; corresponding figures for
persistent pain were 1856 ± 2218 days. Health care seek-
ing was prevalent; 58.9% had visited a physician four or
more times during the previous year.
Effects of MMRP
For the selected outcomes and domains, significant im-
provements were found, except for LISAT-life (Table 2).
The effect sizes were small to medium [60] (Table 2). The
largest effect sizes were found for coping aspects followed
by pain intensity aspects. The area of emotional function-
ing generally showed small effect sizes (Table 2). Detailed
tables including all variables—also including registrations
immediately post MMRP—are shown in Additional file 1:
Tables S2–S5.
Predictions of changes in outcomes at 12-month follow-up
The difference (i.e., changes) between pre and FU-12
values for the selected outcomes were calculated and
transformed if necessary so that an improvement had a
positive value.
Regression of changes in pain intensity aspects
In the regression of changes in the two pain intensity as-
pects (R2 = 0.25, Q2 = 0.16), the strongest regressors among
the background and baseline variables were NRS-7days,
MPI-Pain-severity, MPI-SocSupp, Work/study-now, and
Table 1 Background data for the patients (n = 227)
Variable
Age (years; mean(SD)) 38.1 (10.1)
Women 81.6%
Highest Education (University) 24.1%
Country of origin (Nordic countries) 91.8%
Currently work or studies (Work/study-now) 28.9%
Own prognosis-RTW (very difficult) 36.8%
RTW-when (never) 18.5%
Chances-restored (not at all) 32.3%
Work-importance (very important) 43.0%
Own prognosis-RTW = Prognosis of return to work/studies; RTW-when =When
return to work/studies; Chances-restored = Chances to be fully restored;
Work-importance = Significance of work (except economic)
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LISAT-psychhealth (Table 3, model 1). Hence, improve-
ments in pain intensity aspects were associated with the
following background and baseline variables: high pain in-
tensities, perceiving social support, working/studying, and
satisfaction with psychological health. When excluding the
pain intensity variables at baseline, the explained variation
decreased as expected (Table 3, model 2). In addition, edu-
cation (relative high level), low satisfaction with somatic
health (LISAT11-somhealth), and relatively short persistent
pain duration to some extent were then associated with
improvements in pain intensity aspects.
Regression of changes in emotional functioning
In the regression of changes in three psychological vari-
ables (MPI-Distress, HAD-D, and HAD-A) (R2 = 0.14,
Q2 = 0.10), the strongest regressors of the background
and baseline variables were HAD-A, HAD-D, MPI-
Distress, and SF36-MCS (Table 3, model 1). Hence, im-
provements in psychological status were associated with
high psychological and mental distress at baseline. When
the three psychological variables at baseline were omit-
ted as regressors, the explained variation decreased
(Table 3, model 2). In addition, low life control (MPI-
LifeCon) and low satisfaction with life in general
(LISAT-life) to some extent was associated with im-
provements in the three psychological variables.
Regression of changes in physical functioning
In the regression of changes in physical functioning (i.e.,
MPI-PainInterfer and SF36-PF; R2 = 0.19, Q2 = 0.13), the










NRS-7days 6.8 (1.8) 5.7 (2.2) * 0.51
MPI-Pain-severity 4.3 (0.9) 3.7 (1.3) * 0.61
Physical functioning
MPI-Paininterfer 4.5 (0.9) 3.9 (1.2) * 0.57
SF36-PF 56.1 (19.3) 64.9 (19.5) * 0.45
Emotional functioning
HAD-D 8.2 (4.0) 6.8 (4.3) * 0.33
HAD-A 8.2 (4.3) 7.3 (4.2) * 0.22
MPI-Distress 3.5 (1.2) 3.0 (1.3) * 0.35
Coping
MPI-LifeCon 2.7 (1.1) 3.2 (1.2) * 0.49
CPAQ-AE 25.8 (10.9) 33.8 (11.9) * 0.70
CPAQ-PW 22.5 (8.1) 28.0 (7.9) * 0.69
Tampa 37.6 (8.1) 32.8 (8.0) * 0.60
Health
EQ5D-index 0.33 (0.31) 0.45 (0.32) * 0.38
EQ5D-VAS 36.1 (20.1) 49.3 (21.4) * 0.63
LISAT-life 3.6 (1.3) 3.7 (1.2) ns 0.14
Ratings of global improvement
Retro-pain
Improved (%) 53.6




No change (%) 16.9
Worse (%) 3.0
The selected outcomes were based mainly on the recommendations of IMMPACT. Mean values (SD) together with statistical analyses Pre vs. FU-12 (*p < .00083)
and effect sizes (Cohen’s d) are presented. For the ratings of global improvements are reported percentages (%). Retro-pain = Changes in perception of pain;
Retro-life situation = changes in life in general. The variables were trichotomized into improved, no change, and worsened (%)
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Table 3 Regressions of changes in pain intensity, psychological distress, physical functioning and health (Model 1). In model 2 are excluded the baseline variable used for
calculating the changes
Model 1 Model 1 Model 1 Model 1
Changes in pain intensity
(n = 227)
VIP Sign of Coeff Changes in psychological
distress (n = 227)
VIP Sign of Coeff Changes in physical functioning
(n = 227)
VIP Sign of Coeff Changes in health aspects
(n = 202)
VIP Sign of Coeff
NRS-7days 1.74 + HAD-A 1.49 + SF36-PF 1.73 - EQ5D-VAS 2.01 -
MPI- pain-severity 1.27 + HAD-D 1.24 + RTW-when 1.36 - EQ5D-index 1.52 -
MPI – social support 1.24 + MPI-Distress 1.24 + Own prognosis-RTW 1.27 -
Work/study-now 1.14 + SF36-MCS 1.09 -
LISAT –psychhealth 1.09 +
R2 0.25 R2 0.15 R2 0.17 R2 0.20
Q2 0.16 Q2 0.12 Q2 0.13 Q2 0.12
Model 2 Model 2 Model 2 Model 2
Changes in pain intensity
(n = 227)
VIP Sign of Coeff Changes in psychological
distress
(n = 227)
VIP Sign of Coeff Changes in physical functioning
(n = 227)
VIP Sign of Coeff Changes in health aspects
(n = 197)
VIP Sign of Coeff
MPI- SocSupp 1.36 + SF36-MCS 1.38 - RTW-when 1.48 - Pain-duration-persistent 1.21 -
Work/study-now 1.30 + MPI-LifeCon 1.10 - Own prognosis-RTW 1.38 - Age 1.09 -
LISAT-psychhealth 1.22 + LISAT-life 1.02 - SF36-PSC 1.07 - Pain duration 1.06 -
Education 1.08 + RTW-when 1.04 -
LISAT-somhealth 1.01 - Own prognosis-RTW 1.03 -
Pain-duration-persistent 1.01 - CPAQ-AE 1.02 -
R2 0.14 R2 0.07 R2 0.15 R2 0.05
Q2 0.10 Q2 0.06 Q2 0.06 Q2 0.03
Background and baseline variables (cf. Additional file 1: Table S1) were used as regressors. The significant variables are shown and for each of these are reported VIP (VIP > 1.0 is significant) and the sign of the














three significant regressors were SF36-PF, RTW-when, and
Own prognosis-RTW (Table 3, model 1). Hence, improve-
ments in physical functioning were associated with the fol-
lowing circumstances at baseline: low physical functioning
(SF36-PF), perceptions of relatively soon return to work
(i.e., RTW-when), and relatively easy to return to work (i.e.,
Own prognoisis—RTW). When excluding the two physical
functioning variables at baseline as regressors, the explained
variation decreased (Table 3, model 2). To some extent low
physical health (SF36-PSC) at baseline was associated with
improvements in physical functioning.
Regression of changes in coping aspects
It was not possible to significantly regress the changes in
the four coping aspects (i.e., the 4 Y-variables: MPI-
LifeCon, CPAQ-AE, CPAQ-PW, and Tampa) using the
background and baseline variables as regressors.
Regression of changes in health aspects
In the significant regression of changes in the health
variables (i.e., the two EQ5D variables and LISAT-life;
R2 = 0.19, Q2 = 0.09), the two significant regressors were
EQ5D-VAS and EQ5D-index (Table 3, model 1). Hence,
improvements in health aspects were associated with
low reported health at baseline.
When omitting the health variables at baseline, the ex-
plained variation decreased (Table 3, model 2). Short
pain durations and low age were then associated with
improvements in health aspects.
Retrospective evaluations of pain and in ability to handle
life situation in general
At FU-12, 53.6% retrospectively reported improvements
for pain and 80.1% for general life situation (Table 2).
For Retro-pain, the following background and baseline var-
iables were multivariately important (R2 = 0.11, Q2 = 0.04):
Education (VIP = 1.84 +), MPI-Pain severity (VIP = 1.42-),
EQ5D-index (VIP = 1.07+), and Work-importance (VIP =
1.07-). Hence, improvements were associated with relatively
high education, low pain intensity (MPI-pain-severity), high
health (EQ-5D-index), and perceiving work as important
for reasons other than economic (i.e. Work- importance).
For Retro-life situation, the important variables at baseline
(R2 = 0.09, Q2 = 0.05) were MPI-Pain severity (VIP = 1.77-),
EQ5D-index (VIP = 1.72+), NRS-7days (VIP = 1.25-), and
education (VIP = 1.20+). Hence, improvements in life situ-
ation were associated with low pain intensities (NRS-7days
and MPI-Pain-severity), high health (EQ5D-index), and
relatively high education at baseline.
PCA of outcome variables
To understand to what extent the changes in outcomes of
the different domains together with the two retrospective
items above were independent, a PCA was made for the
situation at FU-12. Only one significant component
(R2 = 0.34; Q2 = 0.24) was achieved according to the
cross-validation rules in SIMCA-P+. The four most im-
portant variables – i.e., highest absolute loadings—were
changes in MPI-PainInterfer (loading = 0.33), MPI-LifeCon
(loading = 0.31), MPI-Pain severity (loading = 0.30), and
MPI-Distress (loading = 0.29). Hence, these four variables
showed the most prominent variability across subjects.
Regression of changes in the four MPI variables
When regressing the changes in the four most im-
portant MPI variables according to the PCA, the
most important background/baseline variables were
MPI-LifeCon (VIP = 2.05-), MPI-Distress (VIP = 1.46+),
and Work–importance (VIP = 1.08-)(R2 = 0.16, Q2 = 0.09,
n = 227). Hence, improvements in these four MPI vari-
ables were associated at baseline with low life control, high
psychological distress, and perceiving work as important
for reasons other than economic.
Discussion
Major results of the present study are listed below.
 The majority of subjects reported benefits of
participating in MMRP according both to the
repeated measurements (i.e., changes from baseline
to FU-12) and to the retrospective evaluations.
 Pain intensity and emotional aspects showed the
strongest improvements (i.e., effect sizes) according
to the repeated measurements.
 The analyses of the repeated measurements showed
that the largest improvements in outcomes were
significantly associated with poor situations
according to their respective baseline scores.
 Although significant regressors of the investigated
domains of outcomes were found, the significant
predictors were weak and only explained a small
part of the variation in outcomes.
Effectiveness of MMRP
This PBE study confirms the generally positive results
for MMRPs according to SRs [16–18], health economics
studies, and 10-year follow-ups [19–21] (Table 2). Both
the repeated measurements (i.e., baseline vs. FU-12) and
the retrospective items (Table 2) showed improvements
for this cohort of patients.
Retrospective evaluations at FU-12
The majority of patients retrospectively reported improve-
ments according to both pain and in their ability to handle
their life situation in general (Table 2). Fortunately and in
agreement with other studies [61, 62], relatively small pro-
portions (3–7%) of the patients reported worse situations
at FU-12 (Table 2). Qualitative explorations have been
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suggested as one way to develop interventions for patients
who do not benefit from MMRP [63].
A mix of background and baseline factors were im-
portant regressors. The two retrospective items had sev-
eral regressors in common. That is, low pain intensity,
high education, and high health perception were related
to improvements. Similar results have been reported in
other studies using retrospective evaluations [33, 61]. In
contrast, a SR of MMRP for fibromyalgia patients sum-
marized that the global treatment effect was predicted
by the MPI dysfunctional profile (i.e., high pain, disabil-
ity, and high solicitous responses from significant others)
and/or worse baseline status [28]. Hence, it is presently
unclear if a relatively good or bad situation with respect
to, for example, pain intensity is associated with im-
provements when evaluated retrospectively.
Changes in outcomes according to the repeated
measurements
In the repeated measurements (i.e., changes from baseline
to FU-12), the most prominent effects according to
Cohen’s d were for emotional and pain aspects (Table 2).
Effect sizes of 0.51–0.61 for the two pain intensity variables
at FU-12 were found (Table 2) and in fact both variables
showed increasing effect sizes over time (Additional file 1:
Tables S2 and S4). These results were in contrast to some
SRs, which reported no evidence for efficacy with respect
to pain intensity [16, 17]. Many pain patients consider pain
intensity as the most important aspect to improve in treat-
ments. Several of the included RCTs in SRs of MMRP do
not include pain intensity due to the fact that the interven-
tions are not focussed on the pain itself but rather on its
consequences [16, 17]. Some authors have suggested that it
might be detrimental for the patient to focus on attempting
to control, reduce, or cure pain, since this might shift em-
phasis away from the aspects that are important for the pa-
tient’s health and quality of life, such as daily functioning
and emotional well-being [64, 65]. Although these lines of
arguments appear reasonable, it may ethically problematic
if both clinical practice and research ignore the reports of
the patients regarding pain intensity. Moreover, patients
with high pain intensities require greater reductions in pain
intensity than patients with lower pain intensity levels in
order to obtain clinically important improvements [66]. In
addition to focusing on pain intensity, it might be wise to
focus on the other outcomes emphasised by IMMPACT
when communicating with patients. As an outcome of
MMRP, pain intensity might be associated with problems
when interpreting the results of MMRPs (e.g., a successful
intervention leads to less fear of movement) as the patient
may be more prone to participate in strenuous activities,
which may lead to increased pain intensity in a more active
patient. However, changes in pain intensity, psychological
distress, and coping aspects were positively intercorrelated
in this study, findings that do not support such an ar-
gument. It is presently unclear if a more prominent
focus on pain intensity within the bio-psycho-social
context of MMRP can increase the effect sizes or will
actually diminish them.
A general pattern was observed where changes in out-
comes were significantly predicted by their respective base-
line scores (Table 3, model 1). For example, high pain
intensity at baseline was associated with more prominent
changes in pain intensity aspects. Such results have been
observed in other studies and could be due to the fact that
a more severe initial status gives more room for improve-
ment [61]. Another related explanation could be regression
to the mean [33]. Recently, Bonstra et al. briefly summa-
rized the literature concerning regressors of repeated mea-
sures of outcomes and better outcomes were reported for
patients with high scores on depression, high fear avoid-
ance beliefs, high perceived stress, optimistic attitudes,
low need to socialize, younger age, or high educational
level [61]. Hence, the present results (Table 3, model 1)
and a study of chronic widespread pain generally agree
with that review [33]. In contrast to this literature, a SR
concerning fibromyalgia reported that poor outcomes
were associated with depression at baseline [28]. Differ-
ences across studies with respect to important predictors
may be due to factors such as number of potential prog-
nostic factors, cohort characteristics, chosen outcomes,
and/or content of MMRP [18, 29, 67, 68].
For two of the domains of outcomes—pain intensity
and physical functioning (Table 3, model 1)—additional
background and baseline variables were significant.
Hence, the regression of the pain intensity changes was
also important for satisfaction with psychological health,
working/studying, and relatively high social support at
baseline. For changes in physical functioning, additional
significant regressors were optimistic attitudes towards
RTW (i.e., RTW-when and Own-prognosis–RTW).
Based on the regressions of the changes in the repeated
measurements (Table 3, model 1), it seems important to
choose patients with a relatively severe clinical picture in
order to be able to achieve substantial improvements. It is
reasonable to assume that this is relevant only up to a cer-
tain level of severity. However, even though it was possible
to significantly regress most of the domains of outcomes,
the explained variations (R2) were low (15–25%). Similar re-
sults have been reported by other researchers [61]. Hence,
other—not investigated—factors are important and the
present results concerning significant background and
baseline variables cannot be applied directly in clinical prac-
tice with any precision.
Is high or low pain intensity indicative of positive outcomes?
The importance of the level of pain intensity for positive
outcome differed between the repeated measurements
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and the retrospective evaluations. Improvements in pain
intensity aspects according to the repeated measures
were associated with high pain intensity at baseline
(Table 3, model 1), while in the retrospective evaluations
the improvements were associated with low pain intensity
at baseline. There are several problems with retrospective
items such as recall time, “telescoping”, desirability, and
memory aspects [69–71]. When using retrospective items
to evaluate changes in a treatment context, additional
problems may exist (e.g., overly optimistic assessments)
[72]. Hence, the results concerning predictors for the
retrospective items may have been associated with bias.
On the other hand, repeated evaluations using self-report
questionnaires in intervention studies may be problematic
[73]. The change that the patient undergoes because of
the intervention may affect the interpretations of the
questions when presented at follow-ups. MMRPs aim to
influence the perception and coping of pain, psychological
distress, and various behaviours. Hence, there may be a
risk that the attitude towards the items of the question-
naire changed as a consequence of MMRP. This could
mean that the follow-up tests cannot simply be com-
pared with the test before MMRP. In order to deepen
the knowledge concerning efficacy of MMRPs, objective
registrations (e.g., sick-leave registrations, actigraphic re-
cordings, and qualitative interviews [63]) can be important
additional sources.
Evaluations of outcomes of MMRP
There is a need to develop clinically applicable and stan-
dardized ways to evaluate multiple outcomes of MMPRs
in individual patients in trials and in PBE studies. This
involves both the statistical methods (cf. Statistics) and
strategies for handling multiple outcomes. This study
used different approaches for evaluation of outcomes.
The number of outcomes in MMRPs are generally high;
one SR including 46 RCTs found in median nine out-
comes and that these generally were not divided into
primary and secondary outcomes [16]. In a recent SR,
the outcomes were evaluated separately [74], which may
be problematic if the outcomes are intercorrelated and
in fact they often are as found in the present study. The
present study used 14 outcomes divided into six
domains that were mainly recommendations from
IMMPACT [12, 28, 34]. Different definitions of a posi-
tive outcome of a MMRP trial have been presented such
as the majority of outcomes had to be significantly better
than for the control intervention [16, 17]. The authors
of another SR predetermined primary and secondary
outcomes and what was necessary to classify an interven-
tion as positive before reviewing the RCTs [75].
The analysis of several outcomes may raise an issue of
multiple comparisons and Bonferroni corrections are
frequently applied [76] and recommended in pain trials
[77]. However, this is a conservative approach when the
number of tests increases [76, 78, 79], and this approach
reduces the chances to detect real treatment effects. Fur-
thermore, such corrections were designed for correc-
tions of independent comparisons [78]. The latter is
generally not present when evaluating the outcome of
MMRPs. IMMPACT has presented hierarchical or “gate-
keeping” procedures that do not require adjustment for
multiplicity [77] but a natural hierarchy of the outcomes.
Outcomes may be combined into a single composite
outcome [80], but this may be problematic with respect
to missing cases and when the components of the com-
posite endpoint are measured on different scales such as
non-commensurate outcomes [80].
Multivariate methods that are able to handle non-
commensurate outcomes in one analysis have been pre-
sented [80]. The presently applied PLS regression can
also handle non-commensurate outcomes in one analysis.
We used a more comprehensive approach when regres-
sing four outcomes simultaneously. These four outcomes
were chosen based on the advanced multivariate correl-
ation analysis (PCA). In agreement with the regressions of
the repeated measures for different domains, we found
that a relatively severe clinical presentation at baseline was
associated with improvements.
Limitations
There are several limitations to consider. No control
group was included and outcomes can be due both to
the effects of MMRP and to other factors such as natural
course. On the other hand, these patients on average
had their pain for a considerable period (on average
more than 2500 days), a period that reduces but does
not eliminate the risk that effects are related to the nat-
ural course. Patients participating in MMRPs have often
tried different unimodal treatments with little or no ef-
fects and thus represent a selection of patients. The
present cohort of patients also represents a selection of
patients with the most complicated clinical pictures as
they were referred to a university hospital. Hence, the
generalizability of the present results is limited and the
results of MMRP in primary care may be different. Not
all the MMRP participants answered the questionnaire
at FU-12. The only significant difference at baseline was
a small difference in pain intensity. But bias cannot be
ruled out since the non-responders may have had worse
effects of MMRP than the responders. It was not pos-
sible to analyse our results in relation to the contents
and it was not possible to control for small changes in
content over time. There are no internationally accepted
definitions of MMRP [61, 81] and no taxonomies for the
contents of these programs exist [17, 61], both issues
that hinder further improvements. The general goals of
MMRP may not be relevant to—or seen as relevant
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by—every patient. In the present study, the importance
of the general goals was not investigated and handled
in the regressions. Another limitation is that we have
no records regarding the level of patient attendance
on the programs.
Conclusion
This study—representing the consecutive non-selected
flow of patients in real-world clinical practice settings
using SQRP—confirmed systematic reviews that outcomes
of MMRP are associated with broad positive effects. A
mix of background and baseline variables affected the out-
comes investigated, but the explained variations in out-
comes were low. In the future there is a need to develop a
standardized and relatively simple outcome that can be
used to evaluate a complex intervention such as MMRP
in trials, in clinical evaluations at group level, and for indi-
vidual patients.
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